Post-transplant inflammatory milieu, immunosuppressive agents, episodes of graft rejection, post-graft failure renal replacement therapy, as well as traditional cardiovascular risk factors, such as hypertension, hyperlipidemia, smoking, obesity, chronic kidney disease, proteinuria, and diabetes mellitus, add...
Thus, it is important to define early predictors of kidney damage, less invasive than allograft biopsy. Urinary glycosaminoglycan/proteoglycan concentration and distribution, N-acetyl-尾-(D: )-glucosaminidase (NAG), and monokine induced by... L Bezerra,C Takano,R Castro,... - 《International Ur...
Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentationanti-CD20 antibodykidney-pancreas ... Kristine DyckmansEvelyne LerutPieter GillardMatthias LannooNadine EctorsAnne Hoorens - Nephrology, dialysis, transplantation: official publication of the...
We encountered an unexpected case of PTLD in the cauda equina of a kidney transplant recipient who was being treated with chronic immunosuppressive therapies.The patient was a 39-year-old woman in whom lower limb muscle weakness appeared and progressed rapidly 10 years after kidney transplantation ...
Substantial strides have been made in improving the short-term success after kidney transplantation. Although there has been some progress, there has not been a robust improvement with respect to long-term outcomes. However, there remain many potentially modifiable transplant-specific risks to long-ter...
the risk of developing PTDM is like walking a very thin, very high tightrope," said Taber's colleague at MUSC, Elizabeth Ashcraft, R.Ph., a clinical pharmacist who sees quite a bit of PTDM at the outpatient clinic where she helps treat kidney, pancreas, and liver transplant recipients....
Better prognostication of graft and patient outcomes among kidney transplant recipients with post-transplant lymphoproliferative disease (PTLD) in the rituximab era is needed to inform treatment decisions. Therefore, we sought to estimate the excess risks of death and graft loss in kidney transplant ...
kidney transplant in PR was significantly more diverse than in the NP (richness:P-value = 0.005, entropy:P-value = 0.01) with the same trend persisting at 6 months after kidney transplant (richness:P-value = 0.02, entropy:P-value = 0.02), and with no distinguishable ...
Living Donor Kidney Transplant Recipients and Clinical Trials: Participation Profiles and Impact on Post-Transplant Caredoi:10.1111/j.1600-6143.2006.01504.xClinicaltrialkidneytransplantlivingdonoroutcomesMany transplant physicians believe that transplant candidates who enroll in clinical trials may have better ...
This article discusses a case of disseminated Scedosporium infection in a kidney transplant recipient. Scedosporium spp. are fungi that can cause serious infections in immunocompromised patients, and they are difficult to treat due to their resistance to many antifungal drugs. The patient in this...